Why Do Some Clinic Pages Talk About Consultation Fees But Not Medicine Costs?

When exploring treatment options, especially within emerging areas like prescribed cannabis in the UK, many patients notice that some clinic websites prominently display consultation fees but remain silent on the actual cost of medicines. This opaque pricing can leave patients confused about their true financial commitment.

In this article, we dive into why this happens, clarify common misconceptions, and explain how medicine costs often dominate recurring expenses. Along the way, we'll explain why the detail matters—particularly for prescribed cannabis, which is vaporised (not smoked), and why device costs and safety standards are part of the bigger treatment picture. We’ll also touch on the role of pharmacy and General Pharmaceutical Council (GPhC) regulation to help patients make informed choices.

Headline Fee Marketing: Why Consultation Costs Take Center Stage

Many UK clinics, especially those offering specialised or newer treatments, lead their marketing with consultation fees for a simple reason: it’s a one-off, clearly defined cost that’s easy to communicate.

  • Consultation Fee: A fixed charge for your initial or follow-up appointment.
  • Medicine Costs: Often variable, medicine prices can depend on dosage, brand, quantity, and ongoing prescribing decisions.

Clinics want you to book appointments first, so they showcase low or transparent consultation fees to lower perceived barriers. Medicine costs, which patients will pay repeatedly, can be complex and vary widely depending on individual treatment plans.

This can lead to opaque pricing where the big ongoing cost—the medicine—is almost an afterthought in web listings, buried in small print or not mentioned at all.

Medicine Dominant Recurring Cost: The Real Financial Weight

In most treatment pathways, the medicine itself is the dominant recurring expense, often dwarfing consultation fees over time. Let’s break down what this means financially:

Cost Component Typical One-Off Cost Typical Monthly Cost Notes Consultation Fee £100 - £250 N/A (usually one-off or occasional) Depends on provider; may include initial assessments and reviews Medicine N/A £200 - £800+ Varies by medicine type, dose, and branded vs generic options Device / Delivery System £50 - £300 £10 - £50 (maintenance or replacements) Sometimes included in medicine cost; essential for some treatments (e.g., vaporisers)

Example: For prescribed cannabis vaporisers, the consultation might cost £150 once, but the medicine and device expenses each month can easily be several hundred pounds.

UK Prescribed Cannabis: Vaporised, Not Smoked

A common misconception among patients and some media is that prescribed cannabis in the UK is “smoked.” This is not true—and the difference is critical for safety, regulation, and cost.

Why Vaporisation is the Standard of Care

Prescribed cannabis products in the NHS or private UK clinics are intended to be vaporised rather than combusted (smoked). Vaporisation heats the medicine just enough to release active cannabinoids as an inhalable mist, avoiding the harmful by-products of burning plant material.

  • Combustion: Burning cannabis creates smoke containing tar and carcinogens harmful to lung health.
  • Vaporisation: Gently heats cannabis or oils to deliver cannabinoids without smoke-related toxins.

This distinction matters because it shapes the device technology used, patient safety, and regulatory standards.

The Device as Part of the Treatment

Since delivery devices directly impact how medicine is used, they are a regulated and essential part of the care package—not optional extras.

  • Vaporiser quality influences dosing consistency and reliability.
  • Devices often require a separate purchase or rental, adding to ongoing costs.
  • Clinical guidance and patient safety advice include correct device use, device cleaning, and replacement schedules.

If clinic pages highlight consultation fees but fail to mention device costs, patients risk being unprepared for the full financial and practical impact of treatment.

Pharmacy and GPhC Regulation: The Safeguard Behind the Scenes

In the UK, prescribed medicines—even cannabis-based products—must be dispensed through a registered pharmacy holding a General Pharmaceutical Council (GPhC) licence. This regulation ensures:

  • Medicine quality and integrity
  • Safe storage and handling
  • Accurate dispensing with proper labeling
  • Access to pharmacist advice on dosing and side effects

When medicine costs aren’t upfront on clinic websites, sometimes it’s because the clinic isn’t the actual medicine supplier—they provide the consultation but then send patients to specialist pharmacies who handle the thelondoneconomic prescriptions. Medicine pricing then becomes a separate, regulated matter, which can add complexity to online communication.

What This Means for Patients

Patients must remember that consultation fees are just part of the picture. The pharmacy’s dispensing charges, medicine prices, and device costs add up and usually form the largest ongoing expense. The GPhC ensures these medicines meet safety standards but doesn’t regulate clinic consultation fees, which is why transparency varies.

How to Navigate Opaque Pricing and Hidden Costs

Given all this, how can patients avoid surprises?

  1. Ask for a Full Cost Breakdown: Request detailed pricing for consultations, medicines, devices, and pharmacy dispensing fees before committing.
  2. Check the Pharmacy's Role: Confirm which pharmacy will dispense your medicine and ask about their pricing and delivery costs.
  3. Understand the Delivery Device: Clarify whether the device is included, rented, or purchased separately.
  4. Consult Official or NHS Sources: Prescribed cannabis costs can vary; NHS information may give baseline guidance.
  5. Beware of “Smokable” Claims: If a clinic page talks about “smokable” cannabis prescriptions, it’s not adhering to UK prescribing norms and safety advice.

Summary: Transparency is Key to Avoid Financial Surprises

Clinic websites may use headline fee marketing to attract patients with clear consultation prices, but the medicine (and device) costs dominate your wallet over time. This is especially true for UK prescribed cannabis, which must be vaporised—not smoked—and requires regulated delivery devices. Pharmacy dispensing is tightly controlled by the GPhC, adding an essential layer of safety but also complexity.

Patients should proactively seek full cost information, clarify treatment components, and beware of misleading terminology. Being informed upfront reduces confusion, helps budgeting, and ensures treatment aligns with both medical standards and patient expectations.

Further Resources

  • General Pharmaceutical Council (GPhC) Official Website
  • NHS Information on Cannabis-Based Medicines
  • Medicines and Healthcare products Regulatory Agency (MHRA)